Avadel Pharmaceuticals-adr Share Price

NASDAQ: AVDL

Small Cap

$15.19

-0.21

(-1.40%)

as on September 16, 2025 at 1:29 am IST

$₹

Avadel Pharmaceuticals-adr Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
Day's High
$14.78
Day's Price Range
$15.52
$15.19
2.70%
Downside
2.17%
Upside
52 Week's Low
52 Week's High
$6.38
52-Week Price Range
$16.66
$15.19
58.00%
Downside
9.68%
Upside

Avadel Pharmaceuticals-adr share price movements today

Previous Close: $15.40
Open: $15.33
Volume: 1.3M
Day's Low - High: $14.78 - $15.52
52 Week Low - High: $6.38 - $16.66

Avadel Pharmaceuticals-adr Historical Returns

1 Month Return: + 12.49 %
3 Month Return: + 60.92 %
1 Year Return: + 12.41 %
3 Year Return: + 157.96 %
5 Year Return: 0 %

Avadel Pharmaceuticals-adr Stock Fundamentals & Key Indicators

Check Avadel Pharmaceuticals-adr market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

0.2325

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

0.07

EBITDA

356.0K

Revenue (TTM)

221.1M

Profit Margin

-1.32%

Return On Equity TTM

4182600.00%

Avadel Pharmaceuticals-adr vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Avadel Pharmaceuticals-adr with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Avadel Pharmaceuticals-adr	BUY	$1.5B	NA	NA	-1.32%
United Therapeutics Corporation	BUY	$18.3B	NA	15.8	40.36%
Haleon Plc Spon Ads	BUY	$44.1B	NA	21.8	13.81%
Neurocrine Biosciences Inc.	BUY	$14.1B	36.02%	41.97	13.88%
Zoetis Inc.	BUY	$65.7B	-8.68%	25.51	27.83%

Stock Returns calculator for Avadel Pharmaceuticals-adr Stock including INR - Dollar returns

The Avadel Pharmaceuticals-adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Avadel Pharmaceuticals-adr investment value today

Current value as on today

₹1,15,861

Returns

₹15,861

(+15.86%)

Returns from Avadel Pharmaceuticals-adr Stock

₹10,876 (+10.88%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Avadel Pharmaceuticals-adr Stock

Based on 16 analysts

BUY

93.75%

Buy

6.25%

Hold

0.00%

Sell

Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Avadel Pharmaceuticals-adr. Average target price of $20.2

Avadel Pharmaceuticals-adr Share Price Target

Get share price movements and forecasts by analysts on Avadel Pharmaceuticals-adr.

What analysts predicted

24.8%UPSIDE

Target Price

$20.2

Current Price

$15.19

Analyzed by

16 Analysts

Target

$20.20

Avadel Pharmaceuticals-adr target price $20.2, a slight upside of 24.8% compared to current price of $15.19. According to 16 analysts rating.

Avadel Pharmaceuticals-adr Stock's Interest Amongst Investors

Search interest for Avadel Pharmaceuticals-adr Stock has increased by 68% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:68% versus previous 30 day period

Avadel Pharmaceuticals-adr Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	1	7	19	27	41	50	50	52	68
Gross Profit	0	1	6	18	25	38	43	45	46	61
Operating Income	-28	-49	-35	-24	-26	-12	0	-3	-3	8
EBITDA	-27	-61	-33	-26	-24	-11	1	-1	-3	9
Interest Expense	3	2	1	2	2	2	2	2	2	2
Depreciation	0	0	0	0	0	0	1	0	0	1
Income Before Tax	-31	-64	-36	-28	-27	-14	-2	-4	-4	6
Income Tax Expense	0	0	0	0	0	0	0	0	0	-3
Net Income	-30	-64	-36	-28	-27	-13	-2	-5	-4	9
Net Profit Margin	0.00%	-4306.95%	-517.17%	-147.98%	-100.60%	-33.30%	-5.25%	-10.00%	-9.37%	14.19%

Avadel Pharmaceuticals-adr Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	173	150	172	103	59	22	-	1	27	169
Gross Profit	162	136	156	85	47	16	0	-1	27	153
Operating Income	71	-4	88	-104	-16	-36	-85	-98	-137	-42
EBITDA	115	5	65	-95	-23	-34	-84	-97	-149	-35
Interest Expense	6	0	1	10	12	12	9	12	9	10
Depreciation	-	-	4	7	2	1	0	1	1	2
Income Before Tax	78	-9	91	-113	-38	-5	-93	-111	-160	-49
Income Tax Expense	37	31	24	-17	-5	-12	-15	26	0	0
Net Income	40	-41	67	-95	-33	7	-77	-137	-160	-48
Net Profit Margin	23.47%	-27.47%	38.93%	-92.29%	-56.11%	31.47%	0.00%	-9188.77%	-573.17%	-28.87%

Avadel Pharmaceuticals-adr Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-64	-36	-28	-27	-13	-2	-5	-4	9
Operating Cash Flow	-32	-38	-28	-29	-18	-6	7	-8	12
Investing Cash Flow	-92	9	27	21	10	4	14	12	-8
Financing Cash Flow	91	30	-21	13	0	1	0	0	0
Change in Cash	-33	1	-20	4	-6	0	22	4	7

Avadel Pharmaceuticals-adr Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-41	67	-95	-33	7	-77	-137	-160	-48
Operating Cash Flow	18	16	-82	-38	-48	-77	-70	-128	-46
Investing Cash Flow	-36	-15	-36	38	-69	56	79	-50	51
Financing Cash Flow	-7	-23	112	0	179	0	14	135	15
Change in Cash	-25	-22	-7	0	61	-21	23	-42	20

Global Institutional Holdings in Avadel Pharmaceuticals-adr

Funds	Holdings
HHG PLC	14.04%
Gendell Jeffrey L	6.33%
Brandes Investment Partners & Co	5.86%
BlackRock Inc	5.64%
Two Seas Capital LP	5.11%

See all

Insights on Avadel Pharmaceuticals-adr

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, AVDL has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 months, AVDL stock has moved up by 59.9%
NO EFFECT
Against Peers
In the last 1 year, United Therapeutics Corporation has given 16.9% return, outperforming this stock by 6.9%

About Avadel Pharmaceuticals-adr

avadel pharmaceuticals plc (nasdaq: avdl) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take, helping patients adhere to their prescribed medical treatment and see better results. avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (cns) / sleep, and hospital markets. the company is headquartered in dublin, ireland with operations in st. louis, missouri and lyon, france.

Organisation	Avadel Pharmaceuticals-adr
Headquarters	10 Earlsfort Terrace, Dublin, Ireland, D02 T380
Industry	Health Technology
CEO	Mr. Gregory J. Divis Jr.
E-voting on shares	Click here to vote

Key Management of Avadel Pharmaceuticals-adr

Name	Title
Mr. Thomas S. McHugh	Senior VP, Principal Financial & Accounting Officer and CFO
Mr. Jerad G. Seurer	General Counsel, Company Secretary & Compliance Officer
Mr. Gregory J. Davis	VP of Corporate and Business Development
Mr. Mark W. Elrod	Vice President of Sales
Dr. Jordan S. Dubow M.D., Ph.D.	Consultant
Dr. Jason M. Vaughn	Senior Vice President of Technical Operations
Ms. Jennifer Gudeman PharmD	Senior Vice President of Medical & Clinical Affairs
Mr. Gregory J. Divis Jr.	CEO & Director
Ms. Susan Rodriguez	Chief Operating Officer
Ms. Angie Woods	Vice President of People & Culture

FAQs

What is Avadel Pharmaceuticals-adr share price today?

Avadel Pharmaceuticals-adr share price today is $15.19 as on September 16, 2025 at 1:29 am IST at the close of the market. Avadel Pharmaceuticals-adr share today touched a day high of $15.52 and a low of $14.78.

What is the 52 week high and 52 week low for Avadel Pharmaceuticals-adr share?

Avadel Pharmaceuticals-adr share touched a 52 week high of $16.66 on November 11, 2024 and a 52 week low of $6.38 on April 9, 2025. Avadel Pharmaceuticals-adr stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $15.19,which is 8.82% down from its 52 week high and 138.09% up from its 52 week low.

What is Avadel Pharmaceuticals-adr's market capitalisation today?

Avadel Pharmaceuticals-adr market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Avadel Pharmaceuticals-adr Stock (AVDL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Avadel Pharmaceuticals-adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Avadel Pharmaceuticals-adr Shares that will get you 0.0987 shares as per Avadel Pharmaceuticals-adr share price of $15.19 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Avadel Pharmaceuticals-adr Stock (AVDL) from India?

Indian investors can start investing in Avadel Pharmaceuticals-adr (AVDL) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 1:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Avadel Pharmaceuticals-adr stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 1:42 pm IST). Based on Avadel Pharmaceuticals-adr share’s latest price of $15.19 as on September 16, 2025 at 1:29 am IST, you will get 0.6583 shares of Avadel Pharmaceuticals-adr. Learn more about fractional shares .